Chemours公司财务问题调查 - Labaton Keller Sucharow正在调查The Chemours Company（NYSE: CC）可能违反联邦证券法的行为[1] - Chemours宣布延迟发布2023年第四季度和全年财务结果，股价下跌12.6%[2] - Chemours公司CEO、CFO和首席会计官被暂时停职，股价下跌31.5%[3]

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of The Chemours Company (“Chemours”) dropped over 31% on February 29, 2024, after the company announced that it has placed three top executives on administrative leave pending the completion of an internal review. The company also announced it is delaying the release of its financial results. Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC). What S ...

BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by The Chemours Company ("Chemours" or the "Company") (NYSE:CC). About the Investigation On February 29, 2024, in a Form 8-K filed with the U.S. Securities Exchange Commission, the Company stated that it had placed its President and Chief Executive Officer, Senior Vice President and Chief Financial Officer and Vice President, Controller and Principal Acco ...

公司财务状况 - Chemours公司股价暴跌37.3%，宣布推迟发布2023年第四季度和全年财务结果，并更换CEO、CFO和财务总监[1] - 公司初步估计2023年销售额下降12%，从盈利转为亏损[2] - 公司警告称，2023年全年销售额可能不超过60亿美元，预计去年亏损可能在2.25亿至2.35亿美元之间[6] 高管变动 - Chemours公司董事会宣布CEO Mark Newman、CFO Jonathan Lock和财务总监Camela Wisel被停职，由Denise Dignam和Matt Abbott接任[3] 内部财务问题 - 公司未透露具体原因，但提到了涉及到公司道德热线的报告，可能存在内部财务问题[5] 盈利情况 - 公司去年每股至少亏损1.51美元，远低于分析师预期的每股盈利3美元[7] - 尽管公司称去年有近9亿美元的一次性费用，但即使排除这些费用，公司可能仍会在非GAAP调整基础上实现盈利[8] 总体评价 - 总体而言，Chemours公司面临着严重的财务问题和高管变动，这将是一个非常糟糕的消息日[9]

Chemours公司调查 - Ademi LLP正在调查Chemours可能存在的证券欺诈行为[1] - Chemours可能就其会计、业务运营和前景发表不准确的声明[1] - Chemours董事会已经对其财务报告内部控制的重大弱点进行了调查[3] - Chemours已经暂时将总裁兼首席执行官Mark Newman、高级副总裁兼首席财务官Jonathan Lock以及副总裁、控制人兼首席会计官Camela Wisel停职[3] Ademi LLP专业领域 - Ademi LLP专门从事证券欺诈和股东诉讼[4]

WILMINGTON, Del.--(BUSINESS WIRE)--The Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer (principal financial and accounting officer). Ms. Dignam joined Chemours in 2015 and has served as our President – Titanium Technologies since March 2023 and previously served as our President – Advanced Performance Materials from 2021 to 2023. She previously served ...

Chemours公司董事会变动 - Chemours公司宣布董事会即将发生两项变动[1] - Sandra Phillips Rogers决定不再寻求连任，将继续任职至任期结束，Pamela Fletcher将于2024年3月1日加入董事会[2] - Pamela Fletcher是Delta航空公司前高级副总裁兼首席可持续发展官，曾在GM担任多个重要职务，具有丰富的创新和可持续发展经验[3] Chemours公司及其领先地位 - Chemours公司总裁兼首席执行官Mark Newman对Pam Fletcher的加入表示欢迎，并认为她的经验和创新精神将为董事会带来巨大价值[3] - Chemours公司是全球领先的化学公司，在钛技术、热能与专业解决方案以及先进性能材料领域拥有领先市场地位，为客户提供市场定义产品和化学创新[4]

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of The Chemours Company (“Chemours”) dropped over 12% in intraday trading on February 14, 2024, after announcing it is evaluating its internal control over financial reporting and postponing its fourth quarter and full year 2023 financial results. Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC). What Should Chemours Company Investors Do? If you in ...

BOSTON, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Chemours Co. (NYSE:CC) for potential securities law violations. Investors who have lost money in their Chemours Co. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/cc. What is this all about? After the market close on February 13, 2024, Chemours Co. announced that it would be delaying the release of Q4 and full year 2023 financial r ...

Chemours公司财务延迟 - Chemours公司延迟发布季度财务结果，称需要额外时间[1] - 公司表示延迟是因为需要完成年终报告流程[2] - FactSet预测Chemours将报告每股盈利24美分，营收为13.2亿美元[3]